IRCCS Sacro Cuore Don Calabria Hospital is an accredited Italian provider in the Veneto region that accommodates about 30,000 patients per year, includes 968 beds and employs approximately 1,712. The regional provider has come together with Mario Negri Institute for Pharmacological Research, a nonprofit research institute dedicated to clinical and biomedical research, to conduct the ‘COVER trial’, a 102 patient, prospective, multi-center, randomized, double-blind trial to assess efficacy and safety of Ivermectin for the treatment of initial infection with SARS-CoV-2 infection. Led by infectious and tropical disease expert Dr. Zeno Bisoffi, the study nears launch and will be conducted through August with final reports planned for October 2020. The study will span regions of Italy and Spain.
The Sponsor Collaborative
The Mario Negri Institute for Pharmacological Research was originally funded by Milan philanthropist Mario Negri and founded by Silvio Garattini, a well-known Italian physician, chemist and researcher. The IRCCS Sacro Cuore Don Calabria Hospital commenced operations as a hospital in 1944 and was classified by 1970 as a “Local General Hospital.” Accredited in the V...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).